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ER stress activates the NLRP3 inflammasome via an
UPR-independent pathway
P Menu*,1,5, A Mayor1,5, R Zhou1,2, A Tardivel1, H Ichijo3, K Mori4 and J Tschopp{,1
Uncontrolled endoplasmic reticulum (ER) stress responses are proposed to contribute to the pathology of chronic inflammatory
diseases such as type 2 diabetes or atherosclerosis. However, the connection between ER stress and inflammation remains
largely unexplored. Here, we show that ER stress causes activation of the NLRP3 inflammasome, with subsequent release of the
pro-inflammatory cytokine interleukin-1b. This ER-triggered proinflammatory signal shares the same requirement for reactive
oxygen species production and potassium efflux compared with other known NLRP3 inflammasome activators, but is
independent of the classical unfolded protein response (UPR). We thus propose that the NLRP3 inflammasome senses and
responds to ER stress downstream of a previously uncharacterized ER stress response signaling pathway distinct from the UPR,
thus providing mechanistic insight to the link between ER stress and chronic inflammatory diseases.
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Inflammation is the first response of the immune system to
infection or tissue injury, and is meant to protect the body from
these insults. Prolonged or chronic inflammation, however,
can exacerbate tissue damage and is implicated in the
development of diseases, such as arthritis, neurodegenera-
tive diseases and type 2 diabetes.1 The endoplasmic
reticulum (ER) stress response is a potent, evolutionarily
conserved response to misfolded proteins and cellular
metabolic stress. The inflammatory response is frequently
triggered as a consequence of ER stress, caused by
metabolic problems or by the accumulation of misfolded
proteins.2 Under such conditions, the ER initiates the unfolded
protein response (UPR). This response is initially aimed at
altering the cellular transcriptional and translational programs
to resolve the protein-folding defect, but if the problem persists
it initiates programed cell death. In addition to the intracellular
responses, chronic ER stress can also, by mechanisms that
remain poorly characterized, cause inflammation within
affected tissues.3
Recent years have seen remarkable growth in our
understanding of the cellular and molecular mechanisms
that control the inflammatory response. In particular, proteins
belonging to the NOD-like receptor (NLR) family have
been identified as central players in innate immunity.4,5
Some of these NLRs participate in multiprotein complexes
termed inflammasomes, which mediate caspase-1-depen-
dent maturation of the highly proinflammatory cytokine
interleukin-1b (IL-1b). Of the thus far described inflamma-
somes, the NLRP3 inflammasome is most fully character-
ized.6 In addition to microbial and viral danger
signals (PAMPs), the NLRP3 inflammasome is unique
in that it can sense the presence of endogenous danger
signals that are associated with cellular or tissue damage
or stress (DAMPs), such as uric acid crystals.4 As the
mechanism by which ER stress triggers inflammation
remains poorly understood, we sought to investigate the role
of the NLRP3 inflammasome as a potential sensor of ER
stress.
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Results
We first determined whether induction of ER stress triggers
the maturation of IL-1b. Human macrophages were exposed
to tunicamycin, an inhibitor of GlcNAc-1-phosphate transfer-
ase and thus of glycoprotein synthesis, in order to induce ER
stress. The presence of processed IL-1b was detected in the
supernatant of the human monocytic cell line THP-1 and
primary human monocytes – macrophages following stimula-
tion with tunicamycin (Figures 1a and b). Similarly, induction
of ER stress using Brefeldin A (BFA), which reversibly blocks
protein transport from the ER to the Golgi, also caused IL-1b
maturation and secretion. (Figures 1a and b). Thapsigargin,
which induces ER stress by blocking ER SERCA pumps and
thereby depleting ER Ca2þ stores, also led to IL-1b secretion,
although exclusively in primary cells (Figure 1a and data not
shown). Taken together, these data suggest that induction of
ER stress by three different compounds results in the release
of mature IL-1b by human macrophages.
The NLRP3 inflammasome is composed of NLRP3,
Cardinal, the adaptor ASC and caspase-1, and mediates the
production of active IL-1b in response to an ever-expanding
list of stimuli.4 A second inflammasome is constituted of the
NLR member NLRC4 and caspase-1, and senses the PAMP
flagellin, while a third inflammasome senses DNA via AIM2.
While all inflammasomes described thus far (the NLRP3,
AIM2, NLRC4 and NLRP1 inflammasomes) sense various
PAMPs, only the NLRP3 inflammasome has been shown to
respond to a plethora of DAMPs as well. We therefore
hypothesized that NLRP3 is the inflammasome sensor
activated by ER stress.
To confirm the specific involvement of the NLRP3 inflam-
masome, we induced ER stress in THP-1 cells in which
NLRP3, ASC and caspase-1 were knocked-down using
shRNA. We found that secretion of IL-1b was markedly
reduced in cells deficient in NLRP3, ASC and caspase-1, but
not NLRC4 (Supplementary Figure 1, and data not shown).
The specific involvement of the NLRP3 inflammasome was
further confirmed by performing similar experiments in murine
macrophages isolated fromNlrp3/, Asc/ orNlrc4/mice
(Figures 2a–c). Moreover, ER stress-induced inflammasome
activation is independent of toll-like or RIG-I-like receptors,
as IL-1b secretion was normal in MyD88-, Trif- and
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Figure 1 ER stress triggers the release of mature interleukin-1b by
macrophages. (a) PMA-differentiated THP-1 cells were stimulated with uric acid
crystals (MSU, positive control), BFA, thapsigargin or tunicamycin for 6 h.
Precipitated supernatant and whole-cell extracts were then analyzed by western
blot. (b) Human primary macrophages were stimulated with MSU, BFA
or tunicamycin for 6 h, and analyzed by western blot. IL-b, mature IL-1b; pIL-1b,
proIL-1b; Casp1, mature caspase-1; pCasp1, procaspase-1; SN, supernatant;
xT, whole-cell extract
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Figure 2 ER stress specifically activates the NLRP3 inflammasome. (a–c) LPS-primed bone marrow-derived macrophages from Nlrp3þ /þ , Nlrp3/, Ascþ /þ , Asc/,
Nlrc4þ /þ and Nlrc4/ mice, respectively, were stimulated with MSU, tunicamycin, thapsigargin or BFA as indicated for 6 h, and analyzed by western blot
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Mavs-deficient murine macrophages (Supplementary Figures
2A, B and C).
The mechanism by which the NLRP3 inflammasome is
activated remains unclear,7,8 though recent evidence sug-
gests mitochondria sense and integrate various danger
signals and relay the signal to the NLRP3 inflammasome.9
Nonetheless, both potassium (Kþ ) efflux and an increase of
reactive oxygen species (ROS) are required for NLRP3
inflammasome activation in response to all stimuli tested thus
far. We therefore examined whether these factors are
required for ER stress-induced IL-1b maturation. This was
indeed the case as the addition of ROS scavengers
(Figure 3a) or the inhibition of Kþ efflux (Figure 3b) completely
inhibited IL-1b secretion. Additionally, cytochalasin D treat-
ment, which blocks actin polymerization, failed to block ER
stress-induced IL-1b secretion, suggesting that phagocytosis
is not required akin to other non-particulate NLRP3 agonists
(Figure 3c).
The finding that ER stress, like other NLRP3 activators,
activates the NLRP3 inflammasome in a Kþ efflux- and ROS-
dependent manner suggests that it may also be sensed by
mitochondria. Thus, it is conceivable that ER stress initiates a
signal that is transmitted to mitochondria and then relayed to
the NLRP3 inflammasome. This notion is consistent with the
subcellular localization of NLRP3. In resting cells, NLRP3 is
associated with ER membranes, and then upon activation
translocates to membranes that are positive for markers
of both ER and mitochondria, which likely correspond to
mitochondria-associated membranes (MAMs).9
VDACs are the major channels for the exchange of
metabolites and ions between the mitochondria and other
cellular compartments, including the ER. They are therefore
important for mitochondrial oxidative metabolism and the
generation of ROS. We therefore tested whether dampening
mitochondrial activity by knocking down the expression of
VDACs has an impact on inflammasome activation induced
by ER stress. Akin to MSU, inflammasome activation by
tunicamycin was impaired in cells with downregulated VDAC1
(Figure 3d). Interestingly, VDAC2 knock-down did not affect
IL-1b secretion by tunicamycin, while it substantially
decreased inflammasome activity triggered by MSU or other
NLRP3 activators, as previously reported (Figure 4a and data
not shown).9 This intriguing observation suggests the
existence of different inflammasome activation mechanisms
downstream of ER stress compared with other known NLRP3
activators, possibly at the mitochondrial level.
The cellular response to ER stress results in the activation
of the UPR, which consists of the three main effector
pathways that are initiated by ER-localized transmembrane
proteins, namely IRE1a, PERK and ATF6a. We thus
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Figure 3 Mechanism of ER stress-induced inflammasome activation is similar to that of other known NLRP3 activators. (a, b and c) PMA-differentiated THP-1 cells were
pre-incubated for 30min with 50-mM ammonium pyrrolidinedithiocarbamate, 130-mM extracellular KCl or 2-mM cytochalasin D (Cyto D), respectively, stimulated with MSU,
R837 or tunicamycin for a further 6 h, and analyzed by western blot. (d) PMA-differentiated THP-1 cells overexpressing an anti-VDAC1, anti-VDAC2 or scramble shRNA were
stimulated with MSU or tunicamycin for 6 h, and analyzed by western blot
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investigated the possible role of UPR effectors in inflamma-
some activation. THP-1 cells stably expressing shRNA
against IRE1a or PERK displayed no alteration in the
secretion of mature IL-1b in response to BFA or tunicamycin
treatment (Figures 4a and b and Supplementary Figure 3).
Additionally, macrophages derived from Atf6a/mice did not
differ from WT littermates in their response to thapsigargin or
tunicamycin (Figure 4c). Of note, strong NLRP3 activators like
MSU or R837 did not induce CHOP upregulation (Figure 4a),
suggesting that they do not induce ER stress and their ability
to activate the inflammasome is thus also independent of an
ER stress response.
The UPR results in widespread blockage of the translation
of most proteins through phosphorylation of eIF2a. Simulta-
neously, it selectively induces the transcription and translation
of proteins initially involved in pro-survival pathways to help
the cell cope with and resolve the cause of ER stress, and
subsequently to initiate programed cell death if the ER stress
is excessive or prolonged. Overall, most downstream
effectors of the UPR are thus transcription-dependent.
While synthesis of the ER stress response effector CHOP
was blocked by the transcriptional inhibitor actinomycin D,
inflammasome activation was not affected (Figure 4d). This
observation further suggests that activation of the NLRP3
inflammasome by ER stress is not dependent on the UPR.
As signaling pathways triggered by the UPR appeared to be
dispensable, we next investigated the role of alternative
signaling pathways that were shown to emanate from a
stressed ER.2 ER stress is proposed to trigger NF-kB
activation through the interaction between IRE1a and the
IKK complex via the adaptor TRAF2.10,11 In line with the
observation that IRE1a is not required (see above), THP-1
cells expressing an shRNA against TRAF2 responded
normally to NLRP3 agonists (Supplementary Figure 4a).
We next investigated a possible role of the JNK signaling
pathway. ER stress-induced JNK activation is thought to be
triggered by a TRAF2- and ASK1- (a stress-activatedMAP3K)
dependent pathway. However, neither TRAF2 nor ASK1 were
required for inflammasome activation in response to ER
stress, as both THP-1 cells with knock-downed TRAF2
and macrophages from Ask1/ mice responded normally
(Supplementary Figures 4A and B).
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Discussion
In this study, we demonstrated that three different com-
pounds (BFA, tunicamycin and thapsigargin), that are known
to induceER stress, also activate theNLRP3 inflammasome in
human and murine macrophages. The activation mechanism
is similar to that of other known NLRP3 activators, requiring
ROS generation and potassium efflux. A minor observed
discrepancy lies in the VDAC1, but not VDAC2, requirement
for activation of the inflammasome by ER stressors, possibly
suggesting the existence of different signaling pathways
triggered by the various NLRP3 activators.
Interestingly, we could not find a role for the well-known ER
stress effectors PERK, IRE1a or ATF6a in NLRP3 inflamma-
some activation. Consequently, we thus rule out the involve-
ment of the classical UPR in this signaling pathway, and
suggest that an UPR-independent ‘fourth branch’ of the ER
stress response regulates NLRP3 inflammasome activation.
As such, we do not offer definitive proof that ER stress per se
is responsible for NLRP3 inflammasome activation. Indeed,
it could be argued that BFA, tunicamycin and thapsigargin
could each have specific, ER-independent, inflammasome-
activating properties distinct from one another. However, in
keeping with Occam’s razor, we believe that the most
straightforward explanation is that a previously uncharacter-
ized response stemming from a stressed ER, that is distinct
from the UPR, is responsible for the ability of these
compounds to activate the inflammasome. The precise
signaling pathway involved remains elusive, similar to other
NLRP3 activators described to date.
Chronic inflammatory diseases such as diabetes and
atherosclerosis are linked to chronic metabolic dysregulation
and ER stress. ER membranes have long been known to
co-sediment with those from the metabolic hub of the cell,
namely mitochondria. These ER MAMs have a different
composition than the rest of the ER, giving rise to the concept
that they may have specialized functions. Interestingly, we
have previously shown that activation of the NLRP3 inflam-
masome occurs at the MAMs.9 Mitochondria were recently
shown to have a pivotal role in activation of the inflamma-
some, and here we show that ER stress also activates the
inflammasome.
MAMs are known to regulate exchange of metabolites,
lipids and Ca2þ between the ER and mitochondria. These
factors, as well as tight regulation of mitochondrial fusion and
fission, are critical for appropriate mitochondrial activity. We
thus propose a model in which ER stress alters steady-state
communication between the ER and mitochondria, leading to
dysregulated mitochondrial activity, enhanced production of
mitochondrial ROS and thus activation of the NLRP3
inflammasome. Our data suggest that this ER stress-induced
inflammasome activation is independent of the UPR
response. Apart from the UPR response, other signaling
pathways have been described to radiate from the ER or
mitochondria such as the activation of JNK andNF-kB, both of
which were not necessary for inflammasome activation.
Chronic ER stress is observed in obesity, and in cellular
systems ER stress leads to insulin resistance.12 The
results presented here suggest that ER stress-induced
NLRP3 inflammasome activation may contribute to ER
stress-induced disease. This concept is supported by clinical
trials demonstrating an important role of IL-1b (and thus the
inflammasome) in the progression of T2D.13 Blocking IL-1b or
IL-1R leads to an astonishing improvement of glucose and
insulin levels. Another example of a clinical evidence for a
connection between ER stress and the inflammasome
in chronic inflammatory disease comes from patients with
TNF-receptor-associated periodic syndrome (TRAPS).14
TRAPS is similar to cryopyrin-associated periodic syndromes
(CAPS, caused by mutations in NLRP3), in that both diseases
are characterized by recurrent fevers, abdominal and joint
pain and myalgia, similar to symptoms found in CAPS
patients. While CAPS is caused by mutations in NLRP3,
TRAPS is caused by mutations in TNF-R1, which were
originally thought to cause altered shedding of the extra-
cellular portion of TNF-R1.15 More recent findings, however,
suggest that the mutated TNF-R1 traffics abnormally and
accumulates in the ER.14 Moreover, TRAPS-associated
TNF-R1mutants cause enhanced production of mitochondrial
ROS,14 which is a requirement for NLRP3 inflammasome
activation. It is therefore possible that accumulation of the
TNF-R1 in the ER triggers ER stress and mitochondrial
ROS production, thereby causing NLRP3 activation and
subsequent IL-1b release. This would explain the surprising
clinical finding that this classically TNF-driven disease can be
treated with IL-1 inhibitors.16 Considering that the dynamics of
ER–mitochondria interaction has a crucial role in NLRP3
inflammasome activation, targeting ER stress may, as
previously suggested,3 represent an attractive therapeutic
target to combat chronic inflammatory disease.
Materials and Methods
Reagents. Uric acid, LPS, ammonium pyrrolidinedithiocarbamate, nigericin and
actinomycin D were purchased from (Sigma-Aldrich Chemie GmbH, Buchs,
Switzerland). BFA, tunicamycin, thapsigargin, puromycin, phorbol 12-myristate
13-acetate (PMA) were from Alexis (Enzo life Sciences (ELS) AG, Lausen,
Switzerland). Ultra-pure LPS was from Invivogen (LabForce AG, Nunningen,
Switzerland), and potassium chloride from AppliChem (Axon Lab AG,
Baden-Da¨ttwil, Switzerland).
Antibodies. The primary antibodies used in this study were obtained from
Sigma-Aldrich (tubulin), Apotech (Enzo Life Sciences (ELS) AG) (NLRP3), MBL
(LabForce AG) (ASC), Cell Signaling (BioConcept, Allschwil, Switzerland) (human
mature IL-1b, BiP, PERK and VDAC1), Santa Cruz Biotechnology, Inc.
(Heidelberg, Germany) (human caspase-1 and IRE1a), Abcam plc (Cambridge
Science Park, UK) (VDAC2) and Alexis (CHOP). The antibody against mouse
caspase-1 (p20) is a generous gift from Dr Peter Vandenabeele (Ghent University).
The antibody against human pro-IL-1b was produced in-house while that
against mouse-IL-1b was a kind gift from Roberto Solari (GlaxoSmithKline AG,
Mu¨nchenbuchsee, Switzerland). Primary antibodies were generally used at a
1 : 1000 dilution in blocking solution (PBS-0.05% Tween with 5% skim milk).
Generation of THP-1 cells stably expressing shRNA. THP-1 cells
stably expressing shRNA were obtained by lentiviral infection as previously
described.17Plasmids encoding for shRNA against NLRP3, ASC and caspase-1
were homemade and have been described.18 The other shRNA-encoding plasmids
were from Sigma, and their respective sequences were as follows: IRE1a, 50-CCGG
GAGAAGATGATTGCGATGGATCTCGAGATCCATCGCAATCATCTTCTCTTTTT-30;
MyD88, 50-CCGGGCAGAGCAAGGAATGTGACTTCTCGAGAAGTCACATTCCT
TGCTCTGCTTTTT-30; PERK, 50-CCGGCCGTAGTAAGAAATGGATCATCTCGA
GATGATCCATTTCTTACTACGGTTTTT-30; TRAF2, 50-CCGGCGAGACGGTAGA
GGGTGAGAACTCGAGTTCTCACCCTCTACCGTCTCGTTTTT-30 and 50-CCGGC
CCTTGCAGATTCCACGCCATCTCGAGATGGCGTGGAATCTGCAAGGGTTTTT-30;
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VDAC1, 50-CCGGGCAGTTGGCTACAAGACTGATCTCGAGATCAGTCTTGTAG
CCAACTGCTTTTT-30; VDAC2, 50-CCGGGATCTCAACAAGAGCTGTATTCTCGA
GAATACAGCTCTTGTTGAGATCTTTTTTG-30.
Mice. Nlrp3/,19 Asc/,20 IPAF/Nlrc4/,20 Atf6a/21 and Ask1/ 22 mice
have been described. All mice were on C57BL/6 background and were housed at
the University of Lausanne following the Swiss Federal Veterinary Office guidelines.
Cell preparation and stimulation. Human THP-1 cells were maintained in
RPMI 1640 medium (Invitrogen, Life Technologies Europe BV, Zug, Switzerland),
supplemented with 10% fetal calf serum (FCS, PAA Laboratories GmbH, Chemie
Brunschwig AG, Basel, Switzerland) and 1% penicillin–streptomycin (Invitrogen) at
371C and 5% CO2. For experiments, THP-1 cells were differentiated for 3 h with
100-nM PMA on the day before stimulation. Primary murine bone marrow-derived
macrophages were isolated from tibial and femoral bone marrow progenitors as
described, 23 and primed with 100 ng/ml ultra-pure LPS overnight the day
before stimulation. Human primary monocytes were isolated from whole blood
obtained from the Center for Blood Transfusion, Lausanne, Switzerland, using the
OptiPrep TM protocol (Axis-Shield AG, Wa¨denswil, Switzerland) following
the manufacturer’s instructions. Cell extracts and precipitated supernatants were
analyzed by western blot.
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